JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, SEPTEMBER 28, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.5084?guestAccessKey=a4bf6abb-399e-4bbf-b56f-1acffd88fed1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092820
What The Study Did: The likelihood of older adults being excluded in randomized clinical trials for COVID-19 treatment and vaccine interventions is evaluated in this study.
Authors: Sharon K. Inouye, M.D., M.P.H., of Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School in Boston, is the corresponding author.
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.